Interleukin 33, released with hepatectomy, facilitated recurrent disease of cholangiocarcinoma

被引:0
作者
Nagaoka, Satoshi [1 ]
Yamada, Daisaku [1 ]
Eguchi, Hidetoshi [1 ]
Iwagami, Yoshifumi [1 ]
Akita, Hirofumi [1 ]
Asaoka, Tadafumi [1 ]
Noda, Takehiro [1 ]
Gotoh, Kunihito [1 ]
Kobayashi, Shogo [1 ]
Umeshita, Koji [2 ]
Doki, Yuichiro [1 ]
Mori, Masaki [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka, Japan
来源
CANCER SCIENCE | 2018年 / 109卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
J-2075
引用
收藏
页码:718 / 718
页数:1
相关论文
共 50 条
  • [21] CLINICAL SIGNIFICANCE OF INTERLEUKIN (IL)-33 IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Rhee, C. K.
    Yoon, H. K.
    Koh, Y. M.
    Oh, Y. M.
    Lee, S. D.
    RESPIROLOGY, 2014, 19 : 22 - 22
  • [22] Interleukin-33: a novel mediator with a role in distinct disease pathologies
    Kurowska-Stolarska, M.
    Hueber, A.
    Stolarski, B.
    McInnes, I. B.
    JOURNAL OF INTERNAL MEDICINE, 2011, 269 (01) : 29 - 35
  • [23] Interleukin-33 Promotes Disease Progression in Patients with Primary Biliary Cirrhosis
    Sun, Yongqiang
    Zhang, Ji-Yuan
    Lv, Sa
    Wang, Huan
    Gong, Man
    Du, Ning
    Liu, Honghong
    Zhang, Ning
    Jing, Jing
    Zhou, Chao
    Zhang, Fan
    Wang, Zongren
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 234 (04) : 255 - 261
  • [24] Serum Interleukin-33 level in Saudi children with inflammatory bowel disease
    Saadah, Omar I.
    Al-Harthi, Sameer E.
    Al-Mughales, Jamil A.
    Bin-Taleb, Yagoub Y.
    Baeshen, Raed S.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (12): : 16000 - 16006
  • [25] Interleukin-33 System as Potential Biomarker and Therapeutic Target in Kawasaki Disease
    Okada, Seigo
    Yasudo, Hiroki
    Ohnishi, Yuji
    Matsuguma, Chie
    Fukano, Reiji
    Waniishi, Takako
    Hasegawa, Shunji
    CIRCULATION, 2022, 146
  • [26] Interleukin-33 contributes to disease severity in Dengue virus infection in mice
    Marques, Rafael E.
    Besnard, Anne-Gaelle
    Maillet, Isabelle
    Fagundes, Caio T.
    Souza, Danielle G.
    Ryffel, Bernhard
    Teixeira, Mauro M.
    Liew, Foo Y.
    Guabiraba, Rodrigo
    IMMUNOLOGY, 2018, 155 (04) : 477 - 490
  • [27] Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: A case report
    Showalter T.N.
    Omer A.O.
    Fellin F.M.
    Anne P.R.
    Rosato E.L.
    Dicker A.P.
    Journal of Medical Case Reports, 2 (1)
  • [28] IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease
    Perez, Federico
    Ruera, Carolina N.
    Miculan, Emanuel
    Carasi, Paula
    Dubois-Camacho, Karen
    Garbi, Laura
    Guzman, Luciana
    Hermoso, Marcela A.
    Chirdo, Fernando G.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [29] INTERLEUKIN-33 POLYMORPHISMS ARE ASSOCIATED WITH PREMATURE CORONARY ARTERY DISEASE AND CENTRAL OBESITY
    Vargas-Alarcon, G.
    Angeles-Martinez, J.
    Alvarez-Leon, E.
    Posadas, C.
    Posadas, R.
    Cardoso, G.
    Medina, A.
    Juarez, J. G.
    Kimura, E.
    ATHEROSCLEROSIS, 2014, 235 (02) : E66 - E66
  • [30] The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease
    Chih-Sung Liang
    Kuan-Pin Su
    Chia-Lin Tsai
    Jiunn-Tay Lee
    Che-Sheng Chu
    Ta-Chuan Yeh
    Ming-Wei Su
    Guan-Yu Lin
    Yu-Kai Lin
    Hsuan-Te Chu
    Chia-Kuang Tsai
    Fu-Chi Yang
    Alzheimer's Research & Therapy, 12